1. Home
  2. MRUS vs QTWO Comparison

MRUS vs QTWO Comparison

Compare MRUS & QTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • QTWO
  • Stock Information
  • Founded
  • MRUS 2003
  • QTWO 2004
  • Country
  • MRUS Netherlands
  • QTWO United States
  • Employees
  • MRUS N/A
  • QTWO N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • QTWO Computer Software: Prepackaged Software
  • Sector
  • MRUS Health Care
  • QTWO Technology
  • Exchange
  • MRUS Nasdaq
  • QTWO Nasdaq
  • Market Cap
  • MRUS 5.1B
  • QTWO 4.7B
  • IPO Year
  • MRUS 2016
  • QTWO 2014
  • Fundamental
  • Price
  • MRUS $94.38
  • QTWO $63.94
  • Analyst Decision
  • MRUS Buy
  • QTWO Buy
  • Analyst Count
  • MRUS 18
  • QTWO 15
  • Target Price
  • MRUS $93.72
  • QTWO $105.57
  • AVG Volume (30 Days)
  • MRUS 4.2M
  • QTWO 1.8M
  • Earning Date
  • MRUS 10-30-2025
  • QTWO 11-05-2025
  • Dividend Yield
  • MRUS N/A
  • QTWO N/A
  • EPS Growth
  • MRUS N/A
  • QTWO N/A
  • EPS
  • MRUS N/A
  • QTWO 0.07
  • Revenue
  • MRUS $56,228,000.00
  • QTWO $742,949,000.00
  • Revenue This Year
  • MRUS $47.25
  • QTWO $15.18
  • Revenue Next Year
  • MRUS N/A
  • QTWO $10.66
  • P/E Ratio
  • MRUS N/A
  • QTWO $872.95
  • Revenue Growth
  • MRUS 59.77
  • QTWO 13.34
  • 52 Week Low
  • MRUS $33.19
  • QTWO $63.61
  • 52 Week High
  • MRUS $94.56
  • QTWO $112.82
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 86.13
  • QTWO 25.80
  • Support Level
  • MRUS $66.13
  • QTWO $65.99
  • Resistance Level
  • MRUS $94.45
  • QTWO $68.19
  • Average True Range (ATR)
  • MRUS 1.00
  • QTWO 2.44
  • MACD
  • MRUS 1.49
  • QTWO -1.14
  • Stochastic Oscillator
  • MRUS 99.38
  • QTWO 4.43

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About QTWO Q2 Holdings Inc.

Q2 Holdings Inc. is a provider of cloud-based virtual banking solutions for regional financial institutions to deliver mobile banking services to retail and commercial end-users who wish to bank anywhere and anytime. Its solutions operate on an integrated tablet-first platform which provides financial institutions a comprehensive view of account holder activity and meets the regulatory and security requirements applicable to the industry. The firm generates revenue from subscription-based arrangements for software offerings. A large majority of the firm's revenue is generated in the United States.

Share on Social Networks: